1. Home
  2. BSM vs TLX Comparison

BSM vs TLX Comparison

Compare BSM & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Stone Minerals L.P.

BSM

Black Stone Minerals L.P.

HOLD

Current Price

$13.47

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.59

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSM
TLX
Founded
1876
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
BSM
TLX
Price
$13.47
$7.59
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$13.00
$21.00
AVG Volume (30 Days)
448.4K
203.3K
Earning Date
11-03-2025
01-15-2026
Dividend Yield
9.03%
N/A
EPS Growth
N/A
N/A
EPS
1.16
0.04
Revenue
$412,814,000.00
$664,225,558.00
Revenue This Year
$1.33
N/A
Revenue Next Year
$9.53
N/A
P/E Ratio
$11.49
$175.66
Revenue Growth
N/A
55.35
52 Week Low
$11.78
$7.49
52 Week High
$15.60
$30.36

Technical Indicators

Market Signals
Indicator
BSM
TLX
Relative Strength Index (RSI) 44.04 31.75
Support Level $13.30 $7.49
Resistance Level $13.61 $8.22
Average True Range (ATR) 0.28 0.22
MACD -0.08 -0.05
Stochastic Oscillator 18.12 7.77

Price Performance

Historical Comparison
BSM
TLX

About BSM Black Stone Minerals L.P.

Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: